Eton Patents

Patent portfolio assigned to Eton (verified via public assignee records). Eton Pharmaceuticals, US public rare-disease pharma company. Patents confirmed as assignee (Justia/Google Patents; ET-400 patents incl. US 11,904,046). Direct competitors are product-specific and not confirmable from a single fetched source, so left empty to avoid fabrication. No named customers (B2B pharma, sells via distribution/specialty pharmacy).